{"response": {"status": "ok", "userTier": "developer", "total": 1, "content": {"id": "news/2017/jan/11/corrections-and-clarifications", "type": "article", "sectionId": "news", "sectionName": "News", "webPublicationDate": "2017-01-11T21:00:09Z", "webTitle": "Corrections and clarifications", "webUrl": "https://www.theguardian.com/news/2017/jan/11/corrections-and-clarifications", "apiUrl": "https://content.guardianapis.com/news/2017/jan/11/corrections-and-clarifications", "fields": {"headline": "Corrections and clarifications", "bodyText": "\u2022 An article (UK tyres deal adds to Japan\u2019s buying spree, 6 January, page 24) said that Takeda Pharmaceuticals had acquired Cambridge-based Crescendo Biologics for $790m. In fact the two companies signed a collaboration and licence agreement worth up to $790m to develop and commercialise Crescendo\u2019s cancer technology. \u2022 An editing lapse caused an appreciation of Clare Hollingworth, the British foreign correspondent who has died aged 105, to say that she was still calling a newspaper daily looking for a story \u201cin her late 1970s\u201d (Inspiration who dodged bullets and sexism, 11 January, page 2, early editions). \u2022 An article said the boat builders Sunseeker had recently launched a \u00a317m 31ft yacht, too big to fit in a London exhibition centre. It is considerably bigger than that at 131ft (British luxury boat builders toast Brexit sales boost, 7 January, page 24)."}, "isHosted": false, "pillarId": "pillar/news", "pillarName": "News"}}}